Cargando…
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
Tumor surveillance of natural killer (NK) cells is mediated by the cytotoxicity receptor natural-killer group 2 member D (NKG2D). Ligands for NKG2D are generally not expressed on healthy cells, but induced on the surface of malignant cells. To date, NKG2D ligand (NKG2D-L) induction was mainly descri...
Autores principales: | Sauer, M, Schuldner, M, Hoffmann, N, Cetintas, A, Reiners, K S, Shatnyeva, O, Hallek, M, Hansen, H P, Gasser, S, von Strandmann, E P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318661/ https://www.ncbi.nlm.nih.gov/pubmed/27477692 http://dx.doi.org/10.1038/onc.2016.259 |
Ejemplares similares
-
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
por: Schuldner, Maximiliane, et al.
Publicado: (2019) -
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
por: Vyas, Maulik, et al.
Publicado: (2017) -
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
Extracellular vesicle measurements with nanoparticle tracking analysis – An accuracy and repeatability comparison between NanoSight NS300 and ZetaView
por: Bachurski, Daniel, et al.
Publicado: (2019) -
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
por: Valor, Luis M, et al.
Publicado: (2013)